Christopher L. Howard - Aug 4, 2022 Form 4 Insider Report for Acadia Healthcare Company, Inc. (ACHC)

Role
EVP, GC and Secretary
Signature
/s/ Christopher L. Howard
Stock symbol
ACHC
Transactions as of
Aug 4, 2022
Transactions value $
-$1,374,254
Form type
4
Date filed
8/8/2022, 06:52 PM
Previous filing
Apr 13, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACHC Common Stock Options Exercise $311K +6.14K +3.75% $50.75 170K Aug 4, 2022 Direct
transaction ACHC Common Stock Sale -$688K -8.44K -4.97% $81.51 161K Aug 4, 2022 Direct F1
transaction ACHC Common Stock Sale -$998K -12.2K -7.57% $81.67 149K Aug 8, 2022 Direct F2
holding ACHC Common Stock 85.6K Aug 4, 2022 See Footnote F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACHC Stock Option Options Exercise $0 +6.14K $0.00* 0 Aug 4, 2022 Common Stock 6.14K $50.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.65, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.96, inclusive. The reporting person undertakes to provide to Acadia, any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Mr. Howard expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
F4 Includes 25,613 shares held by the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust, 25,613 shares held by the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust and 34,387 shares held by the reporting person's spouse.